Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yu V Rumyantseva"'
Allele-specific PCR with fluorescently labeled probes: criteria for selecting primers for genotyping
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 28, Iss 3, Pp 351-359 (2024)
Single-nucleotide polymorphisms (SNPs) can serve as reliable markers in genetic engineering, selection, screening examinations, and other fields of science, medicine, and manufacturing. Whole-genome sequencing and genotyping by sequencing can detect
Externí odkaz:
https://doaj.org/article/c965d4724b4047eebe50066cb981c664
Autor:
M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 25-33 (2022)
The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG) children and adolescents with acute lymphoblastic leukemia (ALL) treated by the ALL-MB-2002 protoc
Externí odkaz:
https://doaj.org/article/273ffc5c215a492e9db3020d5e11e678
Autor:
E. V. Samochatova, D. D. Baidildina, M. A. Maschan, N. N. Savva, O. P. Khlebnikova, A. V. Shamardina, Yu. E. Mareiko, G. A. Tsaur, T. O. Riger, M. M. Shneider, Yu. V. Rumyantseva, T. V. Nasedkina, T. V. Savitskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-17 (2022)
The use of all-trans retinoic acid (ATRA) drastically improved the results of therapy for acute promyelocytic leukeimia (APL). The high efficiency of the Russian protocol APL-93—98 applied to 62 children and adolescents with APL (event-free and ove
Externí odkaz:
https://doaj.org/article/a1999c503e6849b689ddc0507d049b22
Autor:
R. N. Suprun, Yu. V. Rumyantseva, O. I. Bydanov, L. I. Zharikova, S. N. Lagoiko, V. V. Lebedev, K. L. Kondratchik, E. A. Druy, E. G. Mansurova, T. V. Asekretova, O. E. Murashkina, O. V. Aleynikova, L. G. Fechina, G. V. Bykova, N. I. Ponomareva, N. V. Myakova, A. M. Popov, Yu. V. Olshanskaya, A. N. Kazakova, D. V. Litvinov, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:12-31
Introduction. Down syndrome (DS) is one of the most common chromosomal abnormalities. Children with DS have an increased risk of developing acute lymphoblastic leukemia (ALL). Standard therapy is usually used to treat ALL in children with Down syndro
Autor:
D. V. Litvinov, I. P. Tesakov, L. N. Shelikhova, L. A. Khachatryan, E. A. Zerkalenkova, Yu. V. Olshanskaya, A. Yu. Komkov, A. M. Popov, E. V. Mikhaylova, A. N. Remizov, N. V. Myakova, Yu. V. Rumyantseva, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:100-114
Acute lymphoblastic leukemia (ALL) with translocation t(17;19)(q21-q22;p13) TCF3::HLF (E2A::HLF) accounts for less than 1% of childhood B-lineage ALL. Since the first description, patients with this type of ALL are stratified into high-risk group. Th
Autor:
D. V. Litvinov, N. V. Myakova, O. V. Aleynikova, L. G. Fechina, L. M. Minkina, K. L. Kondratchik, E. V. Inyushkina, K. S. Aslanyan, O. V. Ryskal, L. I. Zharikova, O. I. Bydanov, S. N. Lagoyko, Yu. V. Rumyantseva, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:28-41
This paper presents the results for the patients with acute lymphoblastic leukemia (ALL) from the high-risk group (HRG) treated according to the ALL-MB 2002 Protocol. The registration phase of the study was performed from 15.04.2002 to 01.01.2008. Th
Autor:
A. M. Popov, Y. Yu. Verzhbitskaya, G. A. Tsaur, A. G. Solodovnikov, O. R. Arakaev, O. V. Streneva, O. P Khlebnikova, E. V. Shorikov, L. I. Saveliev, S. N. Lagoyko, Yu. V. Rumyantseva, A. I. Karachunskiy, L. G. Fechina
Publikováno v:
Онкогематология, Vol 10, Iss 4, Pp 44-55 (2015)
191 consecutive unselected children with acute lymphoblastic leukemia aged from 1 to 16 years were enrolled in the study. Bone marrow samples were obtained at the time of initial diagnostics as well as at days 15 (n = 188), 36 (n = 191), and 85 (n =
Externí odkaz:
https://doaj.org/article/0218a3540de14fb58723611f40943264
Autor:
A I Karachunsky, Yu V Rumyantseva, S N Lagoiko, C Bührer, G Tallen, O V Aleinikova, O I Bydanov, N V Korepanova, L V Baidun, T V Nasedkina, A Von Stackelberg, G A Novichkova, A A Maschan, D V Litvinov, N I Ponomareva, K L Kondratchik, E G Mansurova, L G Fechina, O V Streneva, N B Yudina, G R Sharapova, A V Shamardina, I E Gerbek, A P Shapochnik, A G Rumyantsev, G Henze
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 41-50 (2015)
Aim. To determine predictors for decision-making on a differential approach to choosing glucocorticosteroids (GCS) for children and adolescents with acute lymphoblastic leukemia (ALL). Subjects and methods. The analysis covered 1064 primary patients
Externí odkaz:
https://doaj.org/article/147f5ec7da0240dfa743df8a897f13a9
Autor:
Olga Soldatkina, O. I. Bydanov, A. A. Chervova, E. N. Nikitin, S. N. Lagoyko, Elena Zerkalenkova, Yu. V. Rumyantseva, Alexander Popov, Y Olshanskaya, N. M. Timofeyeva, L. I. Zharikova, A. I. Karachunskiy, Anna Kazakova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:97-110
The detection of genetic markers associated with poor prognosis is crucial to the selection of an appropriate treatment plan for B-cell precursor acute lymphoblastic leukemia (BCP-ALL). A hypodiploid karyotype in patients with BCP-ALL has an unfavora
Autor:
Yu. V. Rumyantseva, A. V. Panov, V. S. Tyukova, I. N. Senchikhin, D. I. Mendeleev, E. S. Zhavoronok, S. A. Kedik, A. Zh. Fursova, N. G. Kolosova
Publikováno v:
Pharmaceutical Chemistry Journal. 53:1158-1163
Formation of inclusion complexes from disulfiram and hydroxypropyl-β-cyclodextrin was confirmed using x-ray diffraction, differential scanning calorimetry, and thermogravimetry followed by IR spectroscopy of the evolved gas mixture. Inclusion comple